liu.seSearch for publications in DiVA
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Eradicating Quiescent Tumor Cells by Targeting Mitochondrial Bioenergetics
Linköping University, Department of Medical and Health Sciences, Division of Drug Research. Linköping University, Faculty of Medicine and Health Sciences. Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden.
Department of Oncology-Pathology, Karolinska Institute, SE-171 76 Stockholm, Sweden.
Department of Molecular Biology and Genetics, Gebze Technical University, 41400, Gebze, Kocaeli, Turkey.
Department of Immunology, Genetics and Pathology, Section of Oncology, Uppsala University, Uppsala, Sweden.
Show others and affiliations
2016 (English)In: Trends in cancer, ISSN 2405-8025, E-ISSN 2405-8033, Vol. 2, no 11, p. 7p. 657-663Article, review/survey (Refereed) Published
Abstract [en]

Solid tumors contain slowly proliferating cells that show limited sensitivity to conventional cell cycle-active chemotherapeutic drugs. Tumor cells that are not exposed to therapeutically relevant drug concentrations and/or are insensitive to drugs survive treatment and repopulate tumors between treatment cycles. Cancer cells residing in hypoxic and nutritionally compromised environments are expected to have limited metabolic plasticity and to be susceptible to the manipulation of energy supply pathways. Drug screening campaigns using glucose-depleted tumor cells and 3D tumor cell cultures have resulted in the identification of inhibitors of mitochondrial energy production.

Place, publisher, year, edition, pages
Elsevier, 2016. Vol. 2, no 11, p. 7p. 657-663
National Category
Cell Biology
Identifiers
URN: urn:nbn:se:liu:diva-136133DOI: 10.1016/j.trecan.2016.10.009ISI: 000432227400005PubMedID: 28741504OAI: oai:DiVA.org:liu-136133DiVA, id: diva2:1085310
Available from: 2017-03-28 Created: 2017-03-28 Last updated: 2021-04-21Bibliographically approved

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Zhang, XiaonanD’Arcy, PadraigLinder, Stig
By organisation
Division of Drug ResearchFaculty of Medicine and Health Sciences
In the same journal
Trends in cancer
Cell Biology

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 93 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf